We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+11.39%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$634M
AUM Growth
+$113M
(+22%)
Cap. Flow
+$79.5M
Cap. Flow
% of AUM
12.54%
Top 10 Holdings %
Top 10 Hldgs %
42.47%
Holding
197
New
65
Increased
36
Reduced
30
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$17.1M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$14.1M |
| 3 |
Elevance Health
ELV
|
+$12.8M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$12.6M |
| 5 |
STAAR Surgical
STAA
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$25.1M |
| 2 |
Amazon
AMZN
|
+$13.4M |
| 3 |
Synopsys
SNPS
|
+$8.98M |
| 4 |
Knight Transportation
KNX
|
+$8.3M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.88% |
| 2 | Healthcare | 13.86% |
| 3 | Industrials | 10.8% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Consumer Staples | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
VanEck Semiconductor ETF
SMH
$63.8B
| $38.6M | 6.08% |
+700,000
| New | +$38.1M |
|
|
CTLP
2
DELISTED
Cantaloupe
CTLP
| $32.7M | 5.16% |
4,400,000
+145,500
| +3% | +$901K |
|
3
FTAI Aviation
FTAI
$21.8B
| $30.6M | 4.83% |
2,374,866
+118,642
| +5% | +$1.62M |
|
|
STKL
4
DELISTED
SunOpta
STKL
| $27.7M | 4.37% |
8,425,138
+1,251,508
| +17% | +$4.61M |
|
|
5
Elevance Health
ELV
$83.7B
| $26.7M | 4.21% |
94,500
+47,000
| +99% | +$12.8M |
|
6
Sunrun
RUN
$2.3B
| $26.2M | 4.13% |
1,395,000
-97,250
| -7% | -$1.58M |
|
|
EVA
7
DELISTED
Enviva Inc.
EVA
| $25.2M | 3.98% |
800,442
-139,761
| -15% | -$4.43M |
|
|
JE
8
DELISTED
Just Energy Group Inc
JE
| $22M | 3.48% |
155,537
+69,931
| +82% | +$8.43M |
|
|
9
CALL
Elevance Health
ELV
$83.7B
| $19.8M | 3.12% |
+70,000
| New | +$19.1M |
|
10
Microsoft
MSFT
$2.92T
| $19.8M | 3.12% |
147,500
+10,200
| +7% | +$1.29M |
|
|
11
Walt Disney
DIS
$172B
| $19.3M | 3.05% |
138,250
+129,250
| +1,436% | +$17.1M |
|
12
Upland Software
UPLD
$14.4M
| $17.6M | 2.78% |
38,750
+220
| +0.6% | +$101K |
|
|
AY
13
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $17.1M | 2.7% |
755,289
-39,600
| -5% | -$838K |
|
|
PLAN
14
DELISTED
Anaplan, Inc.
PLAN
| $15.6M | 2.47% |
310,000
+304,500
| +5,536% | +$12.6M |
|
|
ZEN
15
DELISTED
ZENDESK INC
ZEN
| $15.4M | 2.42% |
172,500
-13,500
| -7% | -$1.16M |
|
|
MBII
16
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $13.5M | 2.13% |
10,324,747
| – | – |
|
17
Medifast
MED
$108M
| $12.8M | 2.02% |
100,000
+20,000
| +25% | +$2.78M |
|
18
CALL
GE Aerospace
GE
$377B
| $12.6M | 1.99% |
240,764
-100,318
| -29% | -$4.94M |
|
|
BHVN
19
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $11.4M | 1.8% |
260,500
+250,500
| +2,505% | +$14.1M |
|
20
CALL
Bristol-Myers Squibb
BMY
$130B
| $11.3M | 1.79% |
+250,000
| New | +$11.6M |
|
|
21
STAAR Surgical
STAA
$1.13B
| $11M | 1.74% |
375,000
+365,000
| +3,650% | +$10.5M |
|
22
Advanced Micro Devices
AMD
$741B
| $10.1M | 1.6% |
333,000
+100,000
| +43% | +$2.85M |
|
23
Floor & Decor
FND
$6.14B
| $9.64M | 1.52% |
230,000
-40,000
| -15% | -$1.67M |
|
|
XLNX
24
DELISTED
Xilinx Inc
XLNX
| $8.78M | 1.38% |
74,500
-15,500
| -17% | -$1.81M |
|
25
CALL
iShares China Large-Cap ETF
FXI
$4.27B
| $8.55M | 1.35% |
+200,000
| New | +$8.54M |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q2 2019 Portfolio in Review
As of Q2 2019, Ardsley Advisory Partners held 197 positions worth $634M, up 22% from $521M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Ardsley Advisory Partners deployed $79.5M of net new capital in Q2 2019, opening 65 new positions and adding to 36 existing holdings. Its largest new stake was Organigram Holdings: 250,000 shares worth $6.44M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Celgene Corp, an estimated $25.1M trimmed.
- Ardsley Advisory Partners's largest Q2 2019 buy was Organigram Holdings: 250,000 shares worth $6.44M.
- Ardsley Advisory Partners added most to Walt Disney in Q2 2019, an estimated $17.1M increase.
- Ardsley Advisory Partners's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $25.1M.
- Ardsley Advisory Partners fully exited Amazon in Q2 2019, selling an estimated $13.4M.
- Ardsley Advisory Partners's ten largest holdings make up 42% of its $634M portfolio in Q2 2019.
- Ardsley Advisory Partners opened 65 new positions and closed 49 in Q2 2019.
- Ardsley Advisory Partners's portfolio value rose 22% quarter-over-quarter to $634M.
Based on Ardsley Advisory Partners's 13F filing for Q2 2019, filed 13 Aug 2019.